FRANCIS KNUETTEL II

PrivateCIK: 1433316
Location

FRAMINGHAM, MA

FRANCIS KNUETTEL II (Interim CEO, CFO, Treas & Sec) sold 11.7% of their position (1.50K shares) of PELTHOS THERAPEUTICS INC. on the open market

Open‑market sale worth $40.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 1 sale
InsiderFRANCIS KNUETTEL IICIK 1433316
IssuerPELTHOS THERAPEUTICS INC.CIK 1919246
Officer· Interim CEO, CFO, Treas & Sec
Since Feb 2024
+1.55K
Net shares
Net buyer
$40.3K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
59.50K acquired · 57.95K disposed
Non-Derivative Transactions2

Common Stock

Direct
D · Disposition

Shares

13.95K

Price / share

Trade value

% of position

41.7%
5/22/2026
33.47K19.52K

Common Stock

Indirect
S · Sale

Shares

1.50K

Price / share

$26.84

Trade value

$40.26K

% of position

11.7%
5/22/2026
12.82K11.32K
Total

Net shares

15.45K

Net value

-$40.26K

Derivative Transactions2

Stock Option

Direct
A · Award
Converts to

Common Stock

59.50K shares

Shares

+59.50K

Strike price

13.50

Held after

59.50K

Exercisable

5/22/2026

Stock Option

Direct
D · Disposition
Converts to

Common Stock

42.50K shares

Shares

42.50K

Strike price

13.50

Held after

0.00

Exercisable

5/22/2026
Non-Derivative Holdings (Post-Transaction)1

Common Stock

Indirect
Shares owned10K
Total
10K indirect10K
Derivative Holdings (Post-Transaction)0
No derivative holdings reported
FRANCIS KNUETTEL II — Insider Transaction (Form 4) Filed May 26, 2026 | Finecho